¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹À¯¹æ¾ÏÇÐȸ Á¦18ȸ Ç׾Ͽä¹ý ½ÉÆ÷Áö¾ö : 2022-03-26

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹À¯¹æ¾ÏÇÐȸ Á¦18ȸ Ç׾Ͽä¹ý ½ÉÆ÷Áö¾ö : 2022-03-26
±³À°ÀÏÀÚ : 2022-03-26
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎȦ  
±³À°ÁÖÁ¦ : Á¦18ȸ Ç׾Ͽä¹ý ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : Çѱ¹À¯¹æ¾ÏÇÐȸ
´ã´çÀÚ : Á¤Áö¿µ
¿¬¶ôó : 02-3461-6060  
À̸ÞÀÏ : kbcs@kbcs.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í Á¤È¸¿ø.ÁØȸ¿ø : 5¸¸¿ø / °£È£»ç.Àü°øÀÇ : 3¸¸¿ø / ºñȸ¿ø : 8¸¸¿ø / 65¼¼ÀÌ»ó : ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-26 ¹éµÎȦ 09:10~09:35 Clinical Applications of Gene Expression Signatures in HR+/HER2- Early Breast Cancer  À¯Á¾ÇÑ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 03-26 ¹éµÎȦ 09:35~10:00 Emerging Adjuvant Therapies in HR+/HER2- Early Breast Cancer : Are we ready for prime time?  ¼ÕÁÖÇõ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 03-26 ¹éµÎȦ 10:00~10:25 Systemic treatment in HR+/HER2- Metastatic Breast Cancer : Current status & Future perspectives  ÀÓ½ÂÅÃ(¿¬¼¼ÀÇ´ë) 
Åä·Ð 03-26 ¹éµÎȦ 10:25~10:35 Discussion  () 
È޽Ġ03-26  10:35~10:50 Break  () 
±³À°½Ã°£ 03-26 ¹éµÎȦ 10:50~11:15 Tailored approaches in Neoadjuvant/Adjuvant Systemic Therapy : Escalation vs. De-escalation  ¾È¼º±Í(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 03-26 ¹éµÎȦ 11:15~11:40 Optimize Metastatic HER2+ Breast Cancer with Several anti-HER2 Treatment  ¹Ú°æÈ­(°í·ÁÀÇ´ë) 
Åä·Ð 03-26 ¹éµÎȦ 11:40~11:50 Discussion  () 
½Ä»ç 03-26  11:50~12:50 Lunch  () 
±³À°½Ã°£ 03-26 ¹éµÎȦ 12:50~13:15 Recent advances in Neoadjuvant/Adjuvant Chemotherapy : Immunotherapy, Chemotherapy  ¿øÇý¼º(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-26 ¹éµÎȦ 13:15~13:40 Immune Checkpoint Inhibition for Metastatic TNBC : Is there an optimal combination?  À̼öÀÌ(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 03-26 ¹éµÎȦ 13:40~14:05 Biomarker-driven therapeutic approaches in Metastatic TNBC  Ã¤ÀǼö(°æºÏÀÇ´ë) 
Åä·Ð 03-26 ¹éµÎȦ 14:05~14:15 Discussion  () 
È޽Ġ03-26  14:15~14:30 Break  () 
±³À°½Ã°£ 03-26 ¹éµÎȦ 14:30~14:55 Breast Cancer in Pregnancy  ¹è¼ö¿¬(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-26 ¹éµÎȦ 14:55~15:20 Patients with Cardiac risk factors  Á¤¿ì¹é(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-26 ¹éµÎȦ 15:20~15:45 Systemic Treatment in Older Patients  ±èÁöÇü(¿¬¼¼ÀÇ´ë) 
Åä·Ð 03-26  15:45~15:55 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹À¯¹æ¾ÏÇÐȸ Á¦18ȸ Ç׾Ͽä¹ý ½ÉÆ÷Áö¾ö : 2022-03-26""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2022³â Á¦1Â÷ ´ëÇÑÇÙÀÇÇÐȸ Á¤µµ°ü¸® ½ÉÆ÷Áö¾ö : 2022-03-26
´ÙÀ½±Û ±¹¸³Áß¾ÓÀÇ·á¿ø °ñ´Ù°øÁõ Áø´Ü ¹× Ä¡·á¸¦ À§ÇÑ ¿öÅ©¼ó : 2022-03-26
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
167 °æ±â °í·Á´ëÇб³¾È»êº´¿ø ¾È»ê ¹× ½ÃÈ­Áö¿ª À̺ñÀÎÈÄ°ú Àǻ縦 À§ÇÑ Áý´ãȸ : 2018-08-31 0 1,276 2018-07-28
166 ¼­¿ï Çѱ¹³ú½Å°æ°úÇÐȸ Knowing Brain, Healing Brain : 2018-08-31 0 481 2018-07-28
165 ºÎ»ê 2018 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(8¿ù 31ÀÏ) : 2018-08-31 0 675 2018-07-28
164 ¼­¿ï ´ëÇѺñ´¢±â°úÇÐȸ 2018 KPS-APSU Joint International Symposium : 2018-08-31 0 1,293 2018-07-28
163 °­¿ø ´ëÇѽŻý¾ÆÇÐȸ Á¦9Â÷ ±³À°¼¼¹Ì³ª¥° : 2018-08-31 0 483 2018-07-28
162 Àü³² 2018 ¿ø±¤´ëÇб³º´¿ø ±Ç¿ª¿Ü»ó¼¾ÅÍ ½ÉÆ÷Áö¾ö ¹× The 3rd MERIT Symposium : 2018-08-31 0 709 2018-07-28
161 ¼­¿ï 2018³â Á¦6ȸ ´ë¾ÈºÒ¾ÈÀÇÇÐȸ ¿¬¼ö±³À° : 2018-08-31 0 540 2018-07-28
160 ¼­¿ï ¿øÀڷº´¿ø 2018³âµµ 2Â÷ ¹æ»ç¼±ºñ»óÁø·á ½Å±Ô±³À° (2ÀÏÂ÷) : 2018-08-31 0 617 2018-07-28
159 ¼­¿ï ´ëÇѼºÇü¿Ü°úÇÐȸ ±âÃÊÀÇÇבּ¸ È°¼ºÈ­ ¹× Ãʺ¸ÀÚ¸¦ À§ÇÑ ÄÁÆÛ·±½º : 2018-08-31 0 485 2018-07-28
158 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø 1) °áÇÕÁ¶Á÷ Áúȯ 2) ÇǺÎÁö¹æ Áúȯ : 2018-08-30 0 673 2018-07-28
157 ¼­¿ï Çѱ¹³ú½Å°æ°úÇÐȸ Knowing Brain, Healing Brain : 2018-08-30 0 503 2018-07-28
156 ºÎ»ê 2018 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(8¿ù 30ÀÏ) : 2018-08-30 0 599 2018-07-28
155 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] 3Â÷ »ó´ë°¡Ä¡ °³Æí : 2018-08-30 0 1,005 2018-07-28
154 ¼­¿ï ¿øÀڷº´¿ø 2018³âµµ 2Â÷ ¹æ»ç¼±ºñ»óÁø·á ½Å±Ô±³À° (1ÀÏÂ÷) : 2018-08-30 0 933 2018-07-28
153 ºÎ»ê ´ëÇѾȰúÇÐȸ ÇмúÁý´ãȸ(³ì³»Àå, New trends of glaucoma treatment) : 2018-08-30 0 918 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷